HTA304 The Impact of Different HTA Frameworks on Time to Patient Access: A Case Study Assessing the First Commercial Launch Indications for Lynparza, Tagrisso, Imfinzi, Calquence and Enhertu

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1987
https://www.valueinhealthjournal.com/article/S1098-3015(23)05117-3/fulltext
Title : HTA304 The Impact of Different HTA Frameworks on Time to Patient Access: A Case Study Assessing the First Commercial Launch Indications for Lynparza, Tagrisso, Imfinzi, Calquence and Enhertu
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05117-3&doi=10.1016/j.jval.2023.09.1987
First page :
Section Title :
Open access? : No
Section Order : 11434
Categories :
Tags :
Regions :
ViH Article Tags :